C5b-9 glomerular deposition and tubular α₃β₁-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy

References

• Schena P. IgA nephropathies. In: Cameron S, Davison A, Grunfeld J-P, Kerr D, Ritz E Oxford textbook of clinical nephrology. Oxford: Oxford Medical Publications; 1992. p.339–2.
   Google Scholar
• Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol 2000; 11: 2395–403
   PubMed Web of Science ®Google Scholar
• Segerer S, Nelson P, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152–76
   PubMed Web of Science ®Google Scholar
• Rauterberg EW, Lieberknecht HM, Wingen AM, Ritz E. Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int 1987; 31: 820–9
   PubMed Web of Science ®Google Scholar
• Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006; 17: 1724–34
   PubMed Web of Science ®Google Scholar
• Peruzzi L, Amore A, Cirina P, Trusolino L, Basso G, Ricotti E, et al. Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney Int 2000; 58: 2331–40
   PubMed Web of Science ®Google Scholar
• Coppo R, Peruzzi L, Cirina P, Amore A, Trusolino L, Basso G, et al. The role of integrins in IgA nephropathy. Nephrology 1997; 3: 73–8
   Web of Science ®Google Scholar
• Kazami S, Kondo S, Loster K, Reutter W, Kuhara T, Yasutomo K, et al. α1β1 Integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-β and platelet-derived growth factor-BB. J Am Soc Nephrol 1999; 10: 779–89
   PubMed Web of Science ®Google Scholar
• Kuhara T, Kagami S, Kuroda Y. Expression of β1-integrins on activated mesangial cells in human glomerulonephritis. J Am Soc Nephrol 1997; 8: 1679–87
   PubMed Web of Science ®Google Scholar
• Chan LY, Leung JC, Lai KN. Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure (Review). Clin Exp Nephrol 2004; 8: 297–03
   PubMedGoogle Scholar
• Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005; 18: 503–12
   PubMed Web of Science ®Google Scholar
• D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors (Review). Am J Kidney Dis 2000; 36: 227–37
   PubMed Web of Science ®Google Scholar
• Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M. Factors influencing the response to treatment in primary focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 2000; 15: 1348–56
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis and renal biopsy. The kidney4th ed, BM Brenner. WB Saunders, Boston, MA 1996; 1137–4
   Google Scholar
• Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children Pediatr Nephrol 3:248–53.
   Google Scholar
• Kawasaki Y, Takano K, Suyama K, Isome M, Suzuki H, Sakuma H, et al. Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy. Pediatr Nephrol 2006; 21: 1701–6
   PubMed Web of Science ®Google Scholar
• Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis 1998; 31: 962–70
   PubMed Web of Science ®Google Scholar
• Couser WG. Mediation of immune injury (Review). Clin Invest 1993; 71: 808–11
   PubMedGoogle Scholar
• David S, Biancone L, Caserta C, Bussolati B, Cambi V, Camussi G. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 1997; 12: 51–6
   PubMed Web of Science ®Google Scholar
• Alexopoulos E, Papagianni A, Papadimitriou M. The pathogenic significance of C5b-9 in IgA nephropathy. Nephrol Dial Transplant 1995; 10: 1166–72
   PubMed Web of Science ®Google Scholar
• Hughes J, Nangaku M, Alpers CE, Shankland SJ, Couser WG, Johnson RJ. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol 2000; 278: 747–57
   Web of Science ®Google Scholar
• Hsu SI, Couser WG. Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors?. J Am Soc Nephrol 2003; 14: 186–91
   PubMed Web of Science ®Google Scholar
• Lai KN, Chan LY, Leung JC. Mechanisms of tubulointerstitial injury in IgA nephropathy (Review). Kidney Int (Suppl) 2005; 94: 110–5
   Google Scholar
• Peruzzi L, Trusolino L, Amore A, Gianoglio B, Cirina P, Basso G, et al. Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates α v β5 integrin. Kidney Int 1996; 50: 1310–20
   PubMed Web of Science ®Google Scholar
• Chen CA, Hwang JC, Guh JY, Tsai JC, Chen HC. TGF-β1 and integrin synergistically facilitate the differentiation of rat podocytes by increase in α-smooth muscle actin expression. Transl Res 2006; 148: 134–41
   PubMed Web of Science ®Google Scholar
• Kondo S, Kagami S, Urushihara M, Kitamura A, Shimizu M, Strutz F, et al. Transforming growth factor-β1 stimulates collagen matrix remodeling through increased adhesive and contractive potential by human renal fibroblasts. Biochim Biophys Acta 2004; 1693: 91–100
   PubMed Web of Science ®Google Scholar
• Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, et al. Transforming growth factor-β-dependent and -independent pathways of induction of tubulointerstitial fibrosis in β6(–/–) mice. Am J Pathol 2003; 163: 1261–73
   PubMed Web of Science ®Google Scholar
• Hillis GS, Roy-Chaudhury P, Duthie LA, Stewart KN, Brown PA, Simpson JG, et al. Expression of β1 integrins in IgA nephropathy. Nephrol Dial Transplant 1997; 12: 1137–42
   PubMed Web of Science ®Google Scholar